ASCIA Action, First Aid, Management, Transfer, Travel and Treatment Plans


ASCIA Action Plans for Anaphylaxis (RED)

Current ASCIA Action Plans are the 2023 versions. However, prior versions (2022 and 2021) are still valid for use in 2023.  ASCIA Action Plans do not expire, and therefore the plan is still valid beyond the date of review, which is a guide for patients to see their doctor. For further information about ASCIA Action Plans go to www.allergy.org.au/hp/anaphylaxis/action-plans-for-allergic-reactions-faq 

ASCIA Action Plan for Anaphylaxis (RED) 2023

The general version of this plan is for people with allergies who have been prescribed either brand of adrenaline injector devices.
Device specific versions are available below.
These plans are not for allergic rhinitis (hay fever) due to pollen, dust mite, animals or other inhaled allergens.

ASCIA Action Plan for Drug Allergy (GREEN)

ASCIA Action Plan for Drug (Medication) Allergy (GREEN) 2023

This plan is provided to people with drug (medication) allergies who are not usually prescribed an adrenaline injector, because accidental exposure to drugs can mostly be avoided.  They are usually recommended to wear medical identification, to avoid exposure to drugs used in medical procedures. 

pdfASCIA Action Plan Allergic Reactions Green 2023 

ASCIA Record for Drug (Medication) Allergy (GREEN) 2023

This record should be used in conjunction with the patient’s ASCIA Action Plan for Drug (Medication) Allergy

pdfASCIA Record Drug Allergy 2023 

ASCIA Action Plan for Allergic Reactions (GREEN)

ASCIA Action Plan for Allergic Reactions (GREEN) 2023

This plan is provided to people with allergies who have not been prescribed an adrenaline injector. 

This plan is not for allergic rhinitis (hay fever) due to pollen, dust mite, animals or other inhaled allergens.

ASCIA First Aid Plans for Anaphylaxis (ORANGE)

This plan can be used as a poster or stored with general use adrenaline injectors.

A version of this plan for use by crew on aircraft is available upon request.

For translated versions of the ASCIA First Aid for Anaphylaxis go to www.allergy.org.au/hp/anaphylaxis#ta5

ASCIA First Aid Plan for Anaphylaxis (ORANGE) 2023

The general version of this plan can be used as a poster or stored with either brand of general use adrenaline injector devices. 

Device specific versions are available below.

ASCIA First Aid Plan for Anaphylaxis (ORANGE) 2023 Pictorial Poster

This plan can be used as a poster or stored with general use adrenaline injectors. 

ASCIA Travel Plan for people at risk of anaphylaxis

IMAGE CURRENTLY BEING FINALISED

ASCIA Travel Plan for people at risk of anaphylaxis 2023

This plan should be used with an ASCIA Action Plan for Anaphylaxis.

ASCIA Action Plan and Management Plan for Eczema

ASCIA Action Plan
for Eczema 

pdfASCIA Action Plan for Eczema

ASCIA Stepwise Management
Plan for Eczema

pdfASCIA Stepwise Management Plan for Eczema 2022

ASCIA Action Plan and Management Plan for Eosinophilic Oesophagitis (EoE)

ASCIA Action Plan
for EoE 

pdfASCIA Action Plan for EoE

ASCIA Management Plan
for EoE

pdfASCIA Management Plan EoE

ASCIA Action Plan for FPIES (food protein-induced enterocolitis syndrome) 

ASCIA Action Plan for FPIES (food protein-induced enterocolitis syndrome) 

pdfASCIA Action Plan FPIES 2021 

ASCIA Immunodeficency Plans 

ASCIA SCIg (subcutaneous immunoglobulin) Treatment Plan

pdfASCIA SCIg Treatment Plan 

ASCIA Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy) 

pdfASCIA Transfer Care Plan for patients on IRT (immunoglobulin replacement therapy) 

ASCIA Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy

pdfASCIA Travel Plan for patients on SCIg (subcutaneous immunoglobulin) therapy

ASCIA Management Plan for Hereditary Angioedema (HAE)

 ASCIA Treatment Plan for Allergic Rhinitis

 ASCIA Treatment Plans for Immunotherapy

Content updated June 2023

Mod ASCIA Member
Donate to AIFA
go to NAC website
About ASCIA

ASCIA is the peak professional body of clinical immunology and allergy in Australia and New Zealand
ASCIA promotes and advances the study and knowledge of allergy and other immune diseases

Quick Links

About ASCIA

ASCIA is a registered trademark of the Australasian Society of Clinical Immunology and Allergy. All content is subject to copyright for the Australasian Society of Clinical Immunology and Allergy. Read more...

The content for the website is developed and approved by ASCIA Committee and ASCIA Working Party Members. Read more...

Disclaimer I Privacy

The ASCIA website is intended for use by ASCIA members, health professionals and the general public. The content provided is for education, communication and information purposes only and is not intended to replace or constitute medical advice or treatments. Read more...

ASCIA respects your privacy. Read our privacy policy here...

Sponsors | Advertising

ASCIA does not endorse products from sponsoring organisations, nor is it influenced by sponsoring organisations with regard to the content of education programs and websites. 

The ASCIA website does not accept advertising. Any link to a third-party website does not imply any endorsement by ASCIA.

Information Partner

Official Information Partner of Healthdirect Australia